HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection.

AbstractINTRODUCTION:
Our objective was to evaluate the tumor and normal tissue distribution and nuclear importation properties of [(111)In]-mouse IgG (mIgG) conjugated to tat peptides (GRKKRRQRRRPPQGYG) in athymic mice with subcutaneous BT-474 human breast cancer xenografts.
METHODS:
Tumor and normal tissue uptake was compared after intravenous (iv) or intratumoral injection of [(111)In]-mIgG-tat and [(111)In]-mIgG. Area under the curve (AUC) was estimated for blood, liver, spleen, kidneys and tumor. Nuclear localization was measured by subcellular fractionation and estimated by microdosimetry. Imaging studies were performed with a gamma-camera.
RESULTS:
[(111)In]-mIgG-tat was eliminated from the blood and normal tissues two- to threefold more rapidly after iv injection than [(111)In]-mIgG. Tumor uptake was 4-5% injected dose per gram (%ID/g). Tumor radioactivity after intratumoral injection was initially very high (146-154 %ID/g), but declined 12- to 14-fold by 144 h postinjection. There was greater retention of [(111)In]-mIgG-tat in BT-474 tumors after intratumoral than iv injection, and the AUC (610+/-157 %ID h) was threefold greater than for intratumorally injected [(111)In]-mIgG (200+/-37 %ID h). Tat peptides increased nuclear localization of [(111)In]-mIgG after iv injection in tumor, kidney and liver cells, but only in tumor cells after intratumoral injection. Tumors were not imaged after iv administration but were predominant with intratumorally injected [(111)In]-mIgG and [(111)In]-mIgG-tat. Estimated radiation doses to the nucleus of tumor cells from intratumoral [(111)In]-mIgG-tat were 2.8x10(3) mGy/MBq and were 15-fold higher than for iv injection.
CONCLUSION:
[(111)In]-labeled tat immunoconjugates may have potential for imaging intracellular epitopes or localized Auger electron radiotherapy of tumors.
AuthorsBart Cornelissen, Kristin McLarty, Veerle Kersemans, Deborah A Scollard, Raymond M Reilly
JournalNuclear medicine and biology (Nucl Med Biol) Vol. 35 Issue 1 Pg. 101-10 (Jan 2008) ISSN: 0969-8051 [Print] United States
PMID18158949 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Gene Products, tat
  • Immunoconjugates
  • Indium Radioisotopes
  • Radiopharmaceuticals
Topics
  • Amino Acid Sequence
  • Animals
  • Area Under Curve
  • Cell Line, Tumor
  • Cell Nucleus (metabolism)
  • Female
  • Gene Products, tat (administration & dosage, metabolism)
  • HIV-1
  • Immunoconjugates (administration & dosage, metabolism)
  • Indium Radioisotopes
  • Injections, Intravenous
  • Kidney (metabolism)
  • Liver (metabolism)
  • Mice
  • Molecular Sequence Data
  • Neoplasms, Experimental (diagnostic imaging, metabolism)
  • Radionuclide Imaging
  • Radiopharmaceuticals (administration & dosage, metabolism)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: